[Tumor metastasis and MMP inhibitor]

Hiroshi Sato1

  • 1Kanazawa University, Cancer Research Institute.

Clinical Calcium
|April 4, 2006
PubMed

Insights

Matrix metalloproteinases (MMPs) aid tumor spread by degrading the extracellular matrix. While MMP inhibitors show promise, clinical trial outcomes have been inconsistent, necessitating further research into their therapeutic potential.

Area of Science:

  • Biochemistry
  • Oncology
  • Molecular Biology

Context:

  • Matrix metalloproteinases (MMPs) are crucial enzymes involved in extracellular matrix remodeling.
  • Their role in tumor invasion and metastasis is well-established, particularly in degrading collagen.
  • Despite their significance, clinical applications of MMP inhibitors have faced challenges.

Purpose:

  • To explore the multifaceted roles of MMPs in cancer progression.
  • To review the development and clinical outcomes of MMP inhibitor drugs.
  • To identify potential reasons for the variable success of these therapeutic strategies.

Summary:

  • MMPs facilitate tumor cell invasion and metastasis through the degradation of extracellular matrix components.
  • Clinical trials investigating MMP inhibitors have yielded mixed results, indicating a complex therapeutic landscape.
  • Further investigation is required to optimize the efficacy and application of MMP-targeted therapies.

Impact:

  • Understanding MMP function is critical for developing effective anti-cancer strategies.
  • The findings highlight the need for refined approaches in targeting MMPs for cancer treatment.
  • This research contributes to the ongoing effort to improve patient outcomes in oncology.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
3.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K